Sexual-health research: distinguish the endpoint and delivery route

A shared ingredient does not identify the complete intervention

Sildenafil appears as an oral tablet, in TEMPO’s sublingual blend and in the topical arousal cream. The 1998 placebo-controlled trials examined oral sildenafil for erectile dysfunction. That route and endpoint describe the scope of the result.

TEMPO contains apomorphine, sildenafil, tadalafil and vardenafil. The displayed apomorphine study used a sublingual single-ingredient regimen and an open-label, uncontrolled design. Its observations should remain separate from evidence for the four-ingredient formula.

Sources: PMID 9580646 · PMID 11558862

Desire and erectile function are separate outcomes

The RECONNECT trials examined subcutaneous bremelanotide 1.75 mg in premenopausal women with hypoactive sexual desire disorder. They measured desire and related distress over twenty-four weeks. These endpoints differ from intercourse-success measures in an erectile-function trial.

The catalog’s tadalafil-oxytocin-PT-141 nasal spray combines three ingredients and changes the route relative to the subcutaneous bremelanotide trial. The ingredient records can explain those separate research histories while retaining the nasal blend as its own intervention.

Sources: PMID 31599840

Read a placebo comparison before describing a benefit

The 2015 intranasal oxytocin study enrolled thirty women with sexual dysfunction in a randomized crossover design. Both oxytocin and placebo groups improved over time, without a statistically significant treatment effect. Describing only the improvement would remove the part of the comparison that determines its interpretation.

The single-ingredient oxytocin spray and the three-ingredient nasal blend also have different listed concentrations. Study dose, spray volume and product concentration are separate fields. A comparison needs all the fields the source actually reports.

Sources: PMID 26151620

The formulation network

Each row connects a current product to the ingredient research behind its listed formulation.

Read the source studies

Research synthesis by HealthRX.com, October 5, 2026. The cited sources and linked ingredient pages describe the scope of this comparison.